Cargando…

Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity

BACKGROUND: Both immune-mediated thrombotic thrombocytopenic purpura (iTTP) and septic disseminated intravascular coagulation (DIC) are life-threatening disorders developed by platelet-consuming microvascular thrombi and necessitate immediate therapeutic interventions. Although severe deficiencies o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Shinya, Asakura, Hidesaku, Kubo, Masayuki, Sakai, Kazuya, Miyamoto, Toshihiro, Matsumoto, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969072/
https://www.ncbi.nlm.nih.gov/pubmed/36861115
http://dx.doi.org/10.1016/j.rpth.2023.100076
_version_ 1784897641919807488
author Yamada, Shinya
Asakura, Hidesaku
Kubo, Masayuki
Sakai, Kazuya
Miyamoto, Toshihiro
Matsumoto, Masanori
author_facet Yamada, Shinya
Asakura, Hidesaku
Kubo, Masayuki
Sakai, Kazuya
Miyamoto, Toshihiro
Matsumoto, Masanori
author_sort Yamada, Shinya
collection PubMed
description BACKGROUND: Both immune-mediated thrombotic thrombocytopenic purpura (iTTP) and septic disseminated intravascular coagulation (DIC) are life-threatening disorders developed by platelet-consuming microvascular thrombi and necessitate immediate therapeutic interventions. Although severe deficiencies of plasma haptoglobin in iTTP and factor XIII (FXIII) activity in septic DIC have been reported, few studies have focused on the possibility of using these markers to distinguish between iTTP and septic DIC. OBJECTIVES: We investigated whether the plasma levels of haptoglobin and FXIII activity could be helpful for differential diagnosis. METHODS: Thirty-five patients with iTTP and 30 with septic DIC were enrolled in the study. Patient characteristics, coagulation, and fibrinolytic markers were collected from the clinical data. Plasma haptoglobin and FXIII activities were measured using chromogenic Enzyme-Linked Immuno Sorbent Assay and an automated instrument, respectively. RESULTS: The median plasma haptoglobin level was 0.39 mg/dL and 54.20 mg/dL in the iTTP and septic DIC groups, respectively. The median plasma FXIII activities were 91.3% and 36.3% in the iTTP and septic DIC groups, respectively. In the receiver operating characteristic curve analysis, the cutoff level of plasma haptoglobin was 2.868 mg/dL and the area under the curve was 0.832. The cutoff level for plasma FXIII activity and the area under the curve were 76.0% and 0.931, respectively. The thrombotic thrombocytopenic purpura (TTP)/DIC index was defined by FXIII activity (percentage) and haptoglobin (milligrams per decilitre). Laboratory TTP was defined as an index ≥60 and laboratory DIC <60. The sensitivity and specificity of the TTP/DIC index were 94.3% and 86.7%, respectively. CONCLUSION: The TTP/DIC index, composed of plasma levels of haptoglobin and FXIII activity, is useful in differentiating iTTP from septic DIC.
format Online
Article
Text
id pubmed-9969072
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99690722023-02-28 Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity Yamada, Shinya Asakura, Hidesaku Kubo, Masayuki Sakai, Kazuya Miyamoto, Toshihiro Matsumoto, Masanori Res Pract Thromb Haemost Original Article BACKGROUND: Both immune-mediated thrombotic thrombocytopenic purpura (iTTP) and septic disseminated intravascular coagulation (DIC) are life-threatening disorders developed by platelet-consuming microvascular thrombi and necessitate immediate therapeutic interventions. Although severe deficiencies of plasma haptoglobin in iTTP and factor XIII (FXIII) activity in septic DIC have been reported, few studies have focused on the possibility of using these markers to distinguish between iTTP and septic DIC. OBJECTIVES: We investigated whether the plasma levels of haptoglobin and FXIII activity could be helpful for differential diagnosis. METHODS: Thirty-five patients with iTTP and 30 with septic DIC were enrolled in the study. Patient characteristics, coagulation, and fibrinolytic markers were collected from the clinical data. Plasma haptoglobin and FXIII activities were measured using chromogenic Enzyme-Linked Immuno Sorbent Assay and an automated instrument, respectively. RESULTS: The median plasma haptoglobin level was 0.39 mg/dL and 54.20 mg/dL in the iTTP and septic DIC groups, respectively. The median plasma FXIII activities were 91.3% and 36.3% in the iTTP and septic DIC groups, respectively. In the receiver operating characteristic curve analysis, the cutoff level of plasma haptoglobin was 2.868 mg/dL and the area under the curve was 0.832. The cutoff level for plasma FXIII activity and the area under the curve were 76.0% and 0.931, respectively. The thrombotic thrombocytopenic purpura (TTP)/DIC index was defined by FXIII activity (percentage) and haptoglobin (milligrams per decilitre). Laboratory TTP was defined as an index ≥60 and laboratory DIC <60. The sensitivity and specificity of the TTP/DIC index were 94.3% and 86.7%, respectively. CONCLUSION: The TTP/DIC index, composed of plasma levels of haptoglobin and FXIII activity, is useful in differentiating iTTP from septic DIC. Elsevier 2023-02-08 /pmc/articles/PMC9969072/ /pubmed/36861115 http://dx.doi.org/10.1016/j.rpth.2023.100076 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Yamada, Shinya
Asakura, Hidesaku
Kubo, Masayuki
Sakai, Kazuya
Miyamoto, Toshihiro
Matsumoto, Masanori
Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity
title Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity
title_full Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity
title_fullStr Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity
title_full_unstemmed Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity
title_short Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity
title_sort distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor xiii activity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969072/
https://www.ncbi.nlm.nih.gov/pubmed/36861115
http://dx.doi.org/10.1016/j.rpth.2023.100076
work_keys_str_mv AT yamadashinya distinguishingimmunemediatedthromboticthrombocytopenicpurpurafromsepticdisseminatedintravascularcoagulationusingplasmalevelsofhaptoglobinandfactorxiiiactivity
AT asakurahidesaku distinguishingimmunemediatedthromboticthrombocytopenicpurpurafromsepticdisseminatedintravascularcoagulationusingplasmalevelsofhaptoglobinandfactorxiiiactivity
AT kubomasayuki distinguishingimmunemediatedthromboticthrombocytopenicpurpurafromsepticdisseminatedintravascularcoagulationusingplasmalevelsofhaptoglobinandfactorxiiiactivity
AT sakaikazuya distinguishingimmunemediatedthromboticthrombocytopenicpurpurafromsepticdisseminatedintravascularcoagulationusingplasmalevelsofhaptoglobinandfactorxiiiactivity
AT miyamototoshihiro distinguishingimmunemediatedthromboticthrombocytopenicpurpurafromsepticdisseminatedintravascularcoagulationusingplasmalevelsofhaptoglobinandfactorxiiiactivity
AT matsumotomasanori distinguishingimmunemediatedthromboticthrombocytopenicpurpurafromsepticdisseminatedintravascularcoagulationusingplasmalevelsofhaptoglobinandfactorxiiiactivity